Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies

Details for Australian Patent Application No. 2007216472 (hide)

Owner Trion Pharma GmbH

Inventors Lindhofer, Horst

Agent Freehills

Pub. Number AU-A-2007216472

PCT Pub. Number WO2007/093630

Priority 06003057.4 15.02.06 EP

Filing date 15 February 2007

Wipo publication date 23 August 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/093630 Priority application(s): WO2007/093630

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216474-Microwavable food products

2007216465-ZmTCRR-1 plant signal transduction gene and promoter